Stefan Schmitl
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Feasibility of [68Ga]Ga-FAPI PET Molecular Imaging in Atherosclerosis Compared with [18F]FDG in Oncological Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: October 17, 2025
[177Lu]Lu-PSMA radioligand therapy in systemic therapy-naïve metastatic hormone-sensitive prostate cancer patients: a retrospective study.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 14, 2025
[177Lu]Lu-PSMA radioligand therapy as an initial approach in hormone-sensitive metastatic prostate cancer: a case report.
Journal: Wiener klinische Wochenschrift
Published: September 02, 2025
Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 06, 2025
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease.
Journal: Journal of autoimmunity
Published: April 14, 2025
Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 06, 2025
Quality Assurance Investigations and Impurity Characterization during Upscaling of [177Lu]Lu-PSMAI&T.
Journal: Molecules (Basel, Switzerland)
Published: October 09, 2023
Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study.
Journal: International journal of molecular sciences
Published: June 20, 2023
68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.
Journal: Clinical nuclear medicine
Published: June 05, 2023
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: September 01, 2021
CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication.
Journal: Blood
Published: July 07, 2021
Last Updated: 09/26/2026